Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2000

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Lamivudine

DRUG

Stavudine

Trial Locations (19)

10016

Bellevue Hosp / New York Univ Med Ctr, New York

10032

Columbia Presbyterian Med Ctr, New York

Incarnation Children's Ctr / Columbia Presbyterian Med Ctr, New York

11021

North Shore Univ Hosp, Great Neck

11040

Schneider Children's Hosp, New Hyde Park

13210

SUNY Health Sciences Ctr at Syracuse / Pediatrics, Syracuse

32209

Univ of Florida Health Science Ctr / Pediatrics, Jacksonville

32610

Univ of Florida Gainesville, Gainesville

33161

Univ of Miami (Pediatric), Miami

191044318

Children's Hosp of Philadelphia, Philadelphia

277103499

Duke Univ Med Ctr, Durham

294253312

Med Univ of South Carolina, Charleston

381052794

Saint Jude Children's Research Hosp of Memphis, Memphis

920930672

UCSD Med Ctr / Pediatrics / Clinical Sciences, La Jolla

941430105

UCSF / Moffitt Hosp - Pediatric, San Francisco

981050371

Children's Hospital & Medical Center / Seattle ACTU, Seattle

06504

Yale Univ Med School, New Haven

021155724

Children's Hosp of Boston, Boston

009367344

San Juan City Hosp, San Juan

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000901 - Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children | Biotech Hunter | Biotech Hunter